Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Pazopanib (Primary) ; Anastrozole; Letrozole
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 11 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 11 May 2016 Status changed from recruiting to active, no longer recruiting.